$IPAR
INTERPARFUMS INC Stock $ipar

$ipar Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000175392624001363 Filed on August 06, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$424.6M	$342.2M	$309.2M
YoY Change	15.4%	10.67%	26.36%
Cost Of Revenue	$153.5M	$121.5M	$120.8M
YoY Change	15.42%	0.52%	10.01%
Gross Profit	$271.2M	$220.8M	$188.4M
YoY Change	15.38%	17.17%	39.68%
Gross Profit Margin	63.86%	64.51%	60.92%
Selling, General & Admin	$165.2M	$155.9M	$133.4M
YoY Change	11.75%	16.9%	49.06%
% of Gross Profit	60.91%	70.63%	70.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.181M	$6.002M	$4.252M
YoY Change	40.48%	41.16%	15.57%
% of Gross Profit	2.28%	2.72%	2.26%
Operating Expenses	$165.2M	$155.9M	$133.4M
YoY Change	11.75%	16.9%	49.06%
Operating Profit	$106.0M	$64.83M	$55.02M
YoY Change	21.55%	17.82%	21.2%
Interest Expense	-$5.587M	-$3.651M	$2.276M
YoY Change	-333.08%	-260.41%	-912.86%
% of Operating Profit	-5.27%	-5.63%	4.14%
Other Income/Expense, Net	-$5.588M	-$3.577M	$454.0K
YoY Change	848.73%	-887.89%	38.41%
Pretax Income	$100.4M	$61.25M	$55.48M
YoY Change	15.92%	10.41%	22.07%
Income Tax	$23.57M	$14.65M	$12.96M
% Of Pretax Income	23.48%	23.92%	23.36%
Net Earnings	$62.26M	$36.82M	$34.95M
YoY Change	17.0%	5.35%	26.56%
Net Earnings / Revenue	14.66%	10.76%	11.3%
Basic Earnings Per Share	$1.94	$1.15	$1.09
Diluted Earnings Per Share	$1.93	$1.14	$1.09
COMMON SHARES
Basic Shares Outstanding	32.02M shares	32.02M shares	32.01M shares
Diluted Shares Outstanding	32.27K shares	32.27K shares	32.16K shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.2M	$76.71M	$186.8M
YoY Change	-14.33%	-58.93%	-4.65%
Cash & Equivalents	$78.42M	$38.97M	$74.31M
Short-Term Investments	$78.78M	$37.74M	$112.4M
Other Short-Term Assets	$26.79M	$23.62M	$24.99M
YoY Change	-0.22%	-5.49%	36.54%
Inventory	$412.8M	$433.7M	$360.0M
Prepaid Expenses
Receivables	$354.2M	$299.4M	$236.6M
Other Receivables	$4.984M	$5.050M	$14.73M
Total Short-Term Assets	$956.4M	$857.4M	$823.4M
YoY Change	9.08%	4.12%	21.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$166.4M	$161.1M	$168.3M
YoY Change	2.11%	-4.28%	-12.47%
Goodwill
YoY Change
Intangibles	$290.9M	$282.4M	$292.3M
YoY Change	1.45%	-3.4%
Long-Term Investments
YoY Change
Other Assets	$21.65M	$20.45M	$25.30M
YoY Change	-3.45%	-19.16%	-25.09%
Total Long-Term Assets	$524.2M	$506.6M	$528.2M
YoY Change	1.28%	-4.09%	25.1%
TOTAL ASSETS
Total Short-Term Assets	$956.4M	$857.4M	$823.4M
Total Long-Term Assets	$524.2M	$506.6M	$528.2M
Total Assets	$1.481B	$1.364B	$1.352B
YoY Change	6.18%	0.91%	22.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$96.58M	$108.5M	$91.04M
YoY Change	10.8%	19.19%	9.15%
Accrued Expenses	$166.2M	$145.1M	$194.0M
YoY Change	-16.95%	-25.21%	52.89%
Deferred Revenue
YoY Change
Short-Term Debt	$8.957M	$18.49M	$4.958M
YoY Change	99.04%	273.01%
Long-Term Debt Due	$44.54M	$28.74M	$29.08M
YoY Change	6.63%	-1.16%	117.96%
Total Short-Term Liabilities	$339.6M	$332.4M	$341.7M
YoY Change	-6.48%	-2.7%	45.09%
LONG-TERM LIABILITIES
Long-Term Debt	$134.6M	$108.5M	$138.6M
YoY Change	4.34%	-21.71%	18.07%
Other Long-Term Liabilities	$21.30M	$21.87M	$24.49M
YoY Change	-16.45%	-10.71%	-7.91%
Total Long-Term Liabilities	$134.6M	$108.5M	$138.6M
YoY Change	4.34%	-21.71%	-3.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$339.6M	$332.4M	$341.7M
Total Long-Term Liabilities	$134.6M	$108.5M	$138.6M
Total Liabilities	$474.2M	$440.9M	$480.2M
YoY Change	-3.64%	-8.19%	-9.84%
SHAREHOLDERS EQUITY
Retained Earnings	$762.8M	$724.3M	$669.7M
YoY Change	8.5%	8.15%
Common Stock	$32.00K	$32.00K	$32.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$52.86M	$52.86M	$48.76M
YoY Change	8.41%	8.41%
Treasury Stock Shares
Shareholders Equity	$778.5M	$717.1M	$668.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.481B	$1.364B	$1.352B
YoY Change	6.18%	0.91%	22.61%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	$62.26M	$36.82M	$34.95M
YoY Change	17.0%	5.35%	26.56%
Depreciation, Depletion And Amortization	$6.181M	$6.002M	$4.252M
YoY Change	40.48%	41.16%	15.57%
Cash From Operating Activities	$76.14M	$25.50M	$14.12M
YoY Change	335.09%	80.56%	-409.44%
INVESTING ACTIVITIES
Capital Expenditures	$1.045M	$1.330M	$864.0K
YoY Change	-67.34%	53.94%	-104.86%
Acquisitions
YoY Change
Other Investing Activities	-$37.89M	$37.91M	-$23.23M
YoY Change	-721.16%	-263.22%	-1617.18%
Cash From Investing Activities	-$38.94M	$36.58M	-$24.09M
YoY Change	-1442.62%	-251.85%	48.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	78.00K	-43.88M	-64.88M
YoY Change	-100.6%	-32.36%	66.42%
NET CHANGE
Cash From Operating Activities	76.14M	25.50M	14.12M
Cash From Investing Activities	-38.94M	36.58M	-24.09M
Cash From Financing Activities	78.00K	-43.88M	-64.88M
Net Change In Cash	37.28M	18.20M	-74.84M
YoY Change	410.71%	-124.32%	25.17%
FREE CASH FLOW
Cash From Operating Activities	$76.14M	$25.50M	$14.12M
Capital Expenditures	$1.045M	$1.330M	$864.0K
Free Cash Flow	$75.10M	$24.17M	$13.26M
YoY Change	425.14%	82.3%	0.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32033	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0000822663
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-16469
	dei	Entity Registrant Name EntityRegistrantName	INTER PARFUMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3275609
	dei	Entity Address Address Line1 EntityAddressAddressLine1	551 Fifth Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10176
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	983-2640
	dei	Security12b Title Security12bTitle	Common Stock, $.001 par value per share
	dei	Trading Symbol TradingSymbol	IPAR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32024280	shares
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	38973000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	88462000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	37735000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	94304000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	299375000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	247240000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	433716000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	371859000	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5050000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7012000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	23620000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	29458000	usd
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18919000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	691000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	839026000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161064000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169222000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25858000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28613000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	282379000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	296356000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16849000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	14545000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20454000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21567000	usd
CY2024Q2	us-gaap	Assets Assets	1363992000	usd
CY2023Q4	us-gaap	Assets Assets	1369329000	usd
CY2024Q2	us-gaap	Loans Payable To Bank LoansPayableToBank	18494000	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	4420000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	28743000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	29587000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5949000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5951000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	108509000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	97409000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	145129000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	178880000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8498000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	332436000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	324745000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	108482000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	127897000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21868000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24517000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32024280	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32004660	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100505000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	98565000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	724268000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	693848000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-54864000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-40188000	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9981665	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9981665	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	52864000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	52864000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	717077000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	699393000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	184129000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	192777000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	901206000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892170000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1363992000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1369329000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	342229000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	309244000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	666192000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	620967000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	121472000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	120840000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	243050000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	229606000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	220757000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	188404000	usd
	us-gaap	Gross Profit GrossProfit	423142000	usd
	us-gaap	Gross Profit GrossProfit	391361000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	155929000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	133383000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	290341000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	246061000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	64828000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	55021000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	132801000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	145300000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1941000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2276000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3748000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4633000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-634000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	746000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	270000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-13000	usd
CY2024Q2	us-gaap	Investment Income Net InvestmentIncomeNet	-1076000	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1977000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	1944000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	7359000	usd
CY2024Q2	us-gaap	Other Income OtherIncome	74000	usd
CY2023Q2	us-gaap	Other Income OtherIncome	7000	usd
	us-gaap	Other Income OtherIncome	37000	usd
	us-gaap	Other Income OtherIncome	48000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3577000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	454000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1497000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2761000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	61251000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	55475000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	131304000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	148061000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14653000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12957000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31403000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34635000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	46598000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	42518000	usd
	us-gaap	Profit Loss ProfitLoss	99901000	usd
	us-gaap	Profit Loss ProfitLoss	113426000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9775000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7566000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	22030000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24406000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	36823000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	34952000	usd
	us-gaap	Net Income Loss NetIncomeLoss	77871000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.78
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.77
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32024	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32006	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32033	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32012	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32266	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32162	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32266	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32161	shares
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.75
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.625
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.5
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.3
CY2024Q2	us-gaap	Profit Loss ProfitLoss	46598000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	42518000	usd
	us-gaap	Profit Loss ProfitLoss	99901000	usd
	us-gaap	Profit Loss ProfitLoss	113426000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax	-216000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax	-77000	usd
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax	-1172000	usd
CY2024Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	128000	usd
CY2023Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	64000	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-1709000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5912000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-454000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20494000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13035000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	40342000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	41987000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	123927000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9775000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7566000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24406000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-94000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-21000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-322000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-227000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1715000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	6732000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-3411000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	7966000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	7334000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	14976000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27590000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32376000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34653000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	63195000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	96337000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	901206000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	846934000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	901206000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	846934000	usd
	us-gaap	Profit Loss ProfitLoss	99901000	usd
	us-gaap	Profit Loss ProfitLoss	113426000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12020000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8367000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	715000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-650000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1169000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	70000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	48000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3006000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	2620000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2721000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2987000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	299000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-164000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	59603000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35181000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	71184000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	66144000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6581000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3406000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2873000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2579000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12664000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-23425000	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-437000	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	8531000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26459000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6765000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	80879000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	97079000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	134078000	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	138061000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2122000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3202000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	572000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	228000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	50505000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	37552000	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	4947000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15956000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15958000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1370000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5191000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	47963000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	23707000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	20301000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	11289000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-72012000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-77430000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2711000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-49489000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30402000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88462000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104713000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	74311000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4264000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3189000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	32937000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	30096000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	149000000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	139000000	eur
	us-gaap	Acquisition Costs AcquisitionCosts	3000000	usd
CY2024Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P10Y
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	120000000	eur
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	128500000	usd
	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	one-month Euribor plus 0.75%
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80000000	eur
CY2024Q2	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.02	pure
CY2024Q2	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.011	pure
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	174887000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	158733000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	213126000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	433716000	usd
CY2024Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	50000000	eur
CY2024Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	53500000	usd
CY2022Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P4Y
CY2024Q2	us-gaap	Derivative Swaption Interest Rate DerivativeSwaptionInterestRate	0.02	pure
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	120000000	eur
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	128500000	usd
CY2021Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P10Y
CY2021Q2	us-gaap	Derivative Swaption Interest Rate DerivativeSwaptionInterestRate	0.011	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1700000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3300000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1500000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2900000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2900000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2600000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	800000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2400000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	122100	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.47
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	3200	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	11.9
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	118900	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.81
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	580000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1170000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	630000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1270000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	380000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	770000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	430000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	860000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	308970	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	86.52
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	73.09
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	19620	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	69.81
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	289150	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	87.66
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	170250	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	70.6
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	537565	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y2M12D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7700000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2000000	usd
	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	1370000	usd
	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	224000	usd
	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	840000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1409000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5773000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	36823000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	34952000	usd
	us-gaap	Net Income Loss NetIncomeLoss	77871000	usd
	us-gaap	Net Income Loss NetIncomeLoss	89020000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32024	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32006	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32012	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	242	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	156	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	233	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	149	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32266	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32162	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32266	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32161	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.78
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.41
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50000.00	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	ipar	Number Of Product Lines NumberOfProductLines	1	pure
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	342229000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	309244000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	666192000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	620967000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	36823000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	34952000	usd
	us-gaap	Net Income Loss NetIncomeLoss	89020000	usd
CY2024Q2	us-gaap	Assets Assets	1363992000	usd
CY2023Q4	us-gaap	Assets Assets	1369329000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001753926-24-001363-index-headers.html	Edgar Link	pending
0001753926-24-001363-index.html	Edgar Link	pending
0001753926-24-001363.txt	Edgar Link	pending
0001753926-24-001363-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ipar-20240630.htm	Edgar Link	pending
ipar-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
ipar-20240630_cal.xml	Edgar Link	unprocessable
ipar-20240630_def.xml	Edgar Link	unprocessable
ipar-20240630_lab.xml	Edgar Link	unprocessable
ipar-20240630_pre.xml	Edgar Link	unprocessable
ipar-20240630_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IPAR
INTERPARFUMS INC Stock $ipar

2024 Q3 Form 10-Q Financial Statement

#000175392624001363 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPAR INTERPARFUMS INC Stock $ipar

2024 Q3 Form 10-Q Financial Statement

#000175392624001363 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPAR
INTERPARFUMS INC Stock $ipar